{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intravenous+Hydration&page=2", "query": { "intervention": "Intravenous Hydration", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intravenous+Hydration&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-23T15:12:40.409Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01093131", "title": "Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Contrast Induced Nephropathy" ], "interventions": [ { "name": "Oral hydration", "type": "OTHER" }, { "name": "Oral sodium bicarbonate", "type": "DRUG" }, { "name": "Intravenous Hydration", "type": "OTHER" }, { "name": "Intravenous sodium bicarbonate", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "The Western Pennsylvania Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 0, "start_date": "2005-02", "completion_date": "2010-02", "has_results": false, "last_update_posted_date": "2019-10-04", "last_synced_at": "2026-09-23T15:12:40.409Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01093131" }, { "nct_id": "NCT00548548", "title": "A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Adenocarcinoma" ], "interventions": [ { "name": "Bevacizumab", "type": "DRUG" }, { "name": "Capecitabine", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "5-fluorouracil", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 774, "start_date": "2007-09", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2017-06-14", "last_synced_at": "2026-09-23T15:12:40.409Z", "location_count": 13, "location_summary": "Beverly Hills, California • La Jolla, California • Los Angeles, California + 9 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00548548" }, { "nct_id": "NCT05285371", "title": "Boluses of Ringer's in Surgical Kids (BRiSK Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Dehydration in Children", "Fluid Therapy" ], "interventions": [ { "name": "Urinalysis (UA)", "type": "DIAGNOSTIC_TEST" }, { "name": "Complete Metabolic Panel (CMP)", "type": "DIAGNOSTIC_TEST" }, { "name": "Glucose Stick Test (d-Stick)", "type": "DIAGNOSTIC_TEST" }, { "name": "Medical Chart Review", "type": "OTHER" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "1 Year", "maximum_age": "21 Years", "sex": "ALL", "summary": "1 Year to 21 Years" }, "enrollment_count": 70, "start_date": "2022-02-22", "completion_date": "2024-08-01", "has_results": false, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-09-23T15:12:40.409Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05285371" }, { "nct_id": "NCT02432157", "title": "Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage:", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Subarachnoid Hemorrhage", "Cerebral Vasospasm", "Hyponatremia" ], "interventions": [ { "name": "HTS 3%", "type": "DRUG" }, { "name": "Standard fluid management", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Thomas Jefferson University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 50, "start_date": "2015-01", "completion_date": null, "has_results": false, "last_update_posted_date": "2016-02-11", "last_synced_at": "2026-09-23T15:12:40.409Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02432157" }, { "nct_id": "NCT05013437", "title": "Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "Evomela", "type": "DRUG" }, { "name": "Next Generation Sequencing", "type": "DEVICE" }, { "name": "Prochlorperazine", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Diphenhydramine", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Koen van Besien", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2023-09", "completion_date": "2024-03", "has_results": false, "last_update_posted_date": "2024-04-02", "last_synced_at": "2026-09-23T15:12:40.409Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05013437" }, { "nct_id": "NCT02989571", "title": "The Effects of Increased IV Hydration on Nulliparous Women Undergoing an Induction of Labor", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Labor; Forced or Induced, Affecting Fetus or Newborn" ], "interventions": [ { "name": "Intravenous normal saline administered at 250ml/hr", "type": "DRUG" }, { "name": "Intravenous normal saline administered at 125ml/hr", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MemorialCare Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 180, "start_date": "2016-03", "completion_date": "2020-12", "has_results": false, "last_update_posted_date": "2023-01-20", "last_synced_at": "2026-09-23T15:12:40.409Z", "location_count": 1, "location_summary": "Long Beach, California", "locations": [ { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02989571" }, { "nct_id": "NCT04201704", "title": "Effect of Giving Reduced Fluid in Children After Trauma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Critical Illness", "Pediatrics", "General Surgery", "Fluid Therapy", "Wounds and Injuries" ], "interventions": [ { "name": "Balanced crystalloid solution volume administration", "type": "OTHER" }, { "name": "Packed Erythrocytes Units, Blood Product Unit volume", "type": "OTHER" }, { "name": "Plasma volume", "type": "OTHER" }, { "name": "Platelets volume", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "15 Years", "sex": "ALL", "summary": "6 Months to 15 Years" }, "enrollment_count": 250, "start_date": "2018-08-27", "completion_date": "2027-09", "has_results": false, "last_update_posted_date": "2026-05-07", "last_synced_at": "2026-09-23T15:12:40.409Z", "location_count": 4, "location_summary": "Buffalo, New York • New York, New York • Rochester, New York + 1 more", "locations": [ { "city": "Buffalo", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Rochester", "state": "New York" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04201704" }, { "nct_id": "NCT00902044", "title": "Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Sarcoma" ], "interventions": [ { "name": "Autologous HER2-specific T cells", "type": "GENETIC" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Autologous CAR Positive T cells", "type": "GENETIC" } ], "intervention_types": [ "GENETIC", "DRUG" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 36, "start_date": "2010-02-11", "completion_date": "2032-07", "has_results": false, "last_update_posted_date": "2026-01-26", "last_synced_at": "2026-09-23T15:12:40.409Z", "location_count": 2, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00902044" }, { "nct_id": "NCT03798769", "title": "Supportive Oncology Care at Home for Patients With Pancreatic Cancer Receiving Preoperative FOLFIRINOX", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pancreas Cancer" ], "interventions": [ { "name": "Supportive Oncology Care at Home", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2019-01-31", "completion_date": "2022-09-01", "has_results": false, "last_update_posted_date": "2022-11-22", "last_synced_at": "2026-09-23T15:12:40.409Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03798769" }, { "nct_id": "NCT07784855", "title": "Scheduled IV Fluids in the Supportive Management of Patients Undergoing Chemo-radiotherapy for Head and Neck Cancer", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Squamous Cell Carcinoma of Hypopharynx", "Squamous Cell Carcinoma of Larynx", "Squamous Cell Carcinoma of Oropharynx", "Squamous Cell Carcinoma of Oral Cavity" ], "interventions": [ { "name": "Scheduled IV Hydration", "type": "OTHER" }, { "name": "Clinician Assessment-Based IV Hydration", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "West Virginia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 180, "start_date": "2026-10", "completion_date": "2029-04", "has_results": false, "last_update_posted_date": "2026-08-25", "last_synced_at": "2026-09-23T15:12:40.409Z", "location_count": 6, "location_summary": "Bridgeport, West Virginia • Martinsburg, West Virginia • Morgantown, West Virginia + 3 more", "locations": [ { "city": "Bridgeport", "state": "West Virginia" }, { "city": "Martinsburg", "state": "West Virginia" }, { "city": "Morgantown", "state": "West Virginia" }, { "city": "Parkersburg", "state": "West Virginia" }, { "city": "Princeton", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07784855" } ] }